CV Sciences, Inc.

Stocks

Delayed OTC Markets 17:58:17 16/09/2026 +04			5-day change	1st Jan Change
0.0156 ^USD	-8.24%		-14.12%	-73.45%

08-14	CV Sciences, Inc., Q2 2026 Earnings Call, Aug 13, 2026
08-14	CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Published on 06/02/2026 at 09:50 pm +04 - Modified on 06/02/2026 at 10:50 pm +04

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Greetings, and welcome to CV Sciences 2026 Annual Shareholder Meeting. At this time, I'd like to turn the conference over to your host, Mr. Joseph

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

08-14	CV Sciences, Inc., Q2 2026 Earnings Call, Aug 13, 2026
08-14	CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-02	CV Sciences, Inc. - Shareholder/Analyst Call
05-15	CV Sciences, Inc., Q1 2026 Earnings Call, May 14, 2026
05-15	CV Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-27	CV Sciences, Inc., Q4 2025 Earnings Call, Mar 26, 2026
03-27	CV Sciences Seeks M&A	CI
03-27	CV Sciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
03-26	CV Sciences, Inc. Auditor Raises 'Going Concern' Doubt	CI
11-14	CV Sciences, Inc., Q3 2025 Earnings Call, Nov 13, 2025
11-14	CV Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
11-14	CV Sciences Q3 revenue falls	RE
06/10/25	CV Sciences, Inc. announced that it has received $3 million in funding	CI
12/09/25	CV Sciences, Inc. announced that it has received $1.2 million in funding	CI
14/08/25	CV Sciences, Inc., Q2 2025 Earnings Call, Aug 13, 2025

Duration

Period

Sector